What is the address of BINCHE SOINS?

The registered office of BINCHE SOINS is located at Chaussée de Mons 316, 6150 Anderlues.

Is BINCHE SOINS still active?

Yes. According to the CBE (30 October 2026) BINCHE SOINS is active, legal situation “Normale toestand”, started on 31 August 2007.

Is BINCHE SOINS registered on Peppol?

Yes, BINCHE SOINS is registered on the Peppol network with ID 0208:0891773161.

What is the enterprise number of BINCHE SOINS?

The enterprise number of BINCHE SOINS is BE0891773161.

When was BINCHE SOINS founded?

BINCHE SOINS was founded on 31 August 2007.

Who are the directors of BINCHE SOINS?

According to the 2025 annual accounts, the directors of BINCHE SOINS are: UPH SRL.

Is BINCHE SOINS a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 31 August 2007; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did BINCHE SOINS make in 2025?

BINCHE SOINS posted a profit after taxes of € 321,039 in financial year 2025.

What is the revenue of BINCHE SOINS?

In its most recent annual accounts (2025), BINCHE SOINS reported revenue of € 300,000.

How much does an employee at BINCHE SOINS earn?

The average wage cost per full-time employee at BINCHE SOINS was € 42,300 in 2025: staff costs of € 84,660 for 2 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does BINCHE SOINS have?

According to the 2025 annual accounts, BINCHE SOINS has 2 full-time equivalents (FTE).

BINCHE SOINS (Private Limited) - Anderlues - BE0891773161

Q: What does BINCHE SOINS do?

BINCHE SOINS is registered with the CBE as active in: Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies. Private Limited, started on 31 August 2007, 1 establishment.

Dossier BINCHE SOINS, printed on 30 October 2026 from databakkes.be/en/0891773161/binche-soins. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 54 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

BINCHE SOINS from Anderlues, company number BE0891773161, closed financial year 2025 with a result of € 321,039 after tax. For that financial year BINCHE SOINS recorded revenue of € 300,000 and equity of € 2.4 million. Compared with financial year 2024, the result moved from € 822,981 to € 321,039. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on March 31, 2026.

What it is worth Growing

€ 2.4 million

▲ 3% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 321,039

▼ 61% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 254,137

▲ € 212,998 vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 250,000 paid out

78 % of the profit went to the shareholders, mostly to UPH (100 % of the shares). That is where the money ends up.

People and assets in 2025

Full-time equivalents

▼ 0.4 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost Staff costs are payroll only. Director pay sits with services and miscellaneous goods: € 158,514 in 2025, together with rent, insurance, accountants and other services. The accounts do not split that further.

€ 84,660

▼ 22% vs 2024

€ 42,300 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 39,216

▼ 25% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 11 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 2.2 million

▲ 29% vs 2024

€ 195,502 is repaid this year. At this pace the long-term loan is gone in ≈ 11 years.

Owed to suppliers

€ 11,453

▲ € 11,189 vs 2024

Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 26 days on average.

Taxes and wages

€ 13,218

▼ 69% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Revenue	-	€ 450,000 Revenue 2023: € 450,000 First fiscal year in the series	€ 300,000 Revenue 2024: € 300,000 ▼ 33% vs 2023 (€ 450,000) Unfavourable step	€ 300,000 Revenue 2025: € 300,000 Unchanged (€ 300,000) Unchanged
Gross margin	€ 367,883 Gross margin 2022: € 367,883 First fiscal year in the series	-	-	-
Profit after taxes	€ 483,500 Profit after taxes 2022: € 483,500 First fiscal year in the series	€ 648,277 Profit after taxes 2023: € 648,277 ▲ 34% vs 2022 (€ 483,500) Favourable step	€ 822,981 Profit after taxes 2024: € 822,981 ▲ 27% vs 2023 (€ 648,277) Favourable step	€ 321,039 Profit after taxes 2025: € 321,039 ▼ 61% vs 2024 (€ 822,981) Unfavourable step	▼ 61%
Equity	€ 1,875,172 Equity 2022: € 1,875,172 First fiscal year in the series	€ 2,223,449 Equity 2023: € 2,223,449 ▲ 19% vs 2022 (€ 1,875,172) Favourable step	€ 2,346,430 Equity 2024: € 2,346,430 ▲ 6% vs 2023 (€ 2,223,449) Favourable step	€ 2,417,469 Equity 2025: € 2,417,469 ▲ 3% vs 2024 (€ 2,346,430) Favourable step	▲ 3%
Total debts	€ 1,351,892 Total debts 2022: € 1,351,892 First fiscal year in the series	€ 2,350,934 Total debts 2023: € 2,350,934 ▲ 74% vs 2022 (€ 1,351,892) Unfavourable step	€ 1,892,729 Total debts 2024: € 1,892,729 ▼ 19% vs 2023 (€ 2,350,934) Favourable step	€ 2,849,000 Total debts 2025: € 2,849,000 ▲ 51% vs 2024 (€ 1,892,729) Unfavourable step	▲ 51%
Cash	€ 31,998 Cash 2022: € 31,998 First fiscal year in the series	€ 38,334 Cash 2023: € 38,334 ▲ 20% vs 2022 (€ 31,998) Favourable step	€ 41,139 Cash 2024: € 41,139 ▲ 7% vs 2023 (€ 38,334) Favourable step	€ 254,137 Cash 2025: € 254,137 ▲ € 212,998 vs 2024 (€ 41,139) Favourable step	▲ € 212,998
Land & buildings	€ 1,992,660 Land & buildings 2022: € 1,992,660 First fiscal year in the series	€ 2,825,059 Land & buildings 2023: € 2,825,059 ▲ 42% vs 2022 (€ 1,992,660) Unchanged	€ 2,892,953 Land & buildings 2024: € 2,892,953 ▲ 2% vs 2023 (€ 2,825,059) Unchanged	€ 3,323,752 Land & buildings 2025: € 3,323,752 ▲ 15% vs 2024 (€ 2,892,953) Unchanged	▲ 15%
Retained profit	€ 1,867,972 Retained profit 2022: € 1,867,972 First fiscal year in the series	€ 2,214,389 Retained profit 2023: € 2,214,389 ▲ 19% vs 2022 (€ 1,867,972) Favourable step	€ 2,337,370 Retained profit 2024: € 2,337,370 ▲ 6% vs 2023 (€ 2,214,389) Favourable step	€ 2,408,409 Retained profit 2025: € 2,408,409 ▲ 3% vs 2024 (€ 2,337,370) Favourable step	▲ 3%
Dividend	€ 100,000 Dividend 2022: € 100,000 First fiscal year in the series	€ 300,000 Dividend 2023: € 300,000 ▲ 200% vs 2022 (€ 100,000) Unchanged	€ 700,000 Dividend 2024: € 700,000 ▲ 133% vs 2023 (€ 300,000) Unchanged	€ 250,000 Dividend 2025: € 250,000 ▼ 64% vs 2024 (€ 700,000) Unchanged	▼ 64%
Bank debt	€ 1,238,532 Bank debt 2022: € 1,238,532 First fiscal year in the series	€ 1,664,431 Bank debt 2023: € 1,664,431 ▲ 34% vs 2022 (€ 1,238,532) Unfavourable step	€ 1,708,891 Bank debt 2024: € 1,708,891 ▲ 3% vs 2023 (€ 1,664,431) Unfavourable step	€ 2,201,555 Bank debt 2025: € 2,201,555 ▲ 29% vs 2024 (€ 1,708,891) Unfavourable step	▲ 29%
Balance sheet total	€ 3,227,065 Balance sheet total 2022: € 3,227,065 First fiscal year in the series	€ 4,574,384 Balance sheet total 2023: € 4,574,384 ▲ 42% vs 2022 (€ 3,227,065) Unchanged	€ 4,239,159 Balance sheet total 2024: € 4,239,159 ▼ 7% vs 2023 (€ 4,574,384) Unchanged	€ 5,266,469 Balance sheet total 2025: € 5,266,469 ▲ 24% vs 2024 (€ 4,239,159) Unchanged	▲ 24%
Employees (FTE)	-	2 Employees (FTE) 2023: 2 First fiscal year in the series	2.4 Employees (FTE) 2024: 2.4 ▲ 0.4 vs 2023 (2) Unchanged	2 Employees (FTE) 2025: 2 ▼ 0.4 vs 2024 (2.4) Unchanged	▼ 0.4

Key figures of BINCHE SOINS, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to BINCHE SOINS?

What happened at BINCHE SOINS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Mar 31, 2026 New annual accounts for financial year 2025: profit of € 321,039 (▼ 61% vs 2024). Source: NBB ↗
Aug 31, 2007 New establishment in Anderlues. KBO
Aug 31, 2007 Start of the company according to the CBE. KBO

In short

From € 483,500 profit in 2022 to € 321,039 profit in 2025.

Paid € 129,649 in corporate taxes since 2022.

Best year ever: 2024, with € 822,981 profit.

Paid out € 1.4 million in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

UPH 100%

The stake of UPH comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

BINCHE SOINS

Tarifica Soins 100%

Behind BINCHE SOINS is UPH SRL. The shares are held by UPH (100%). It owns 100% of Tarifica Soins itself.

Directors

According to the 2025 annual accounts

UPH SRL

Director · represented by Urbain Julien

Shareholders

UPH

100%

Participations

Tarifica Soins

100%

Establishments

Establishment units

Physical locations of this company

Registered office

Chaussée de Mons 316

6150 Anderlues

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 4 companies are registered at this address.

All companies at this address →

MEDIC OFFICE

€ 260,004 revenue · 2025

TBS

UPH same network

TARIFICA SOINS same network

€ 29.5 million revenue · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0891.773.161

VAT number

BE 0891.773.161

Registered office

Chaussée de Mons 316, 6150 Anderlues

Names & denominations

BINCHE SOINS

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

31 August 2007

Peppol

Active · Active since 17 Jul 2026

Activities · NACE

Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies

Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering

View on CBE Public ↗ Annual accounts (NBB) ↗

BINCHE SOINS

Warning lights

Financials

What happened to BINCHE SOINS?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions